Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's market cap is currently $3.61B. The company's EPS TTM is $0.168; its P/E ratio is 12.54; and it has a dividend yield of 8.31%. Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 8.22B	¥ 8.25B	¥ 6.91B	¥ 6.60B	¥ 6.99B
Gross Profit	¥ 3.62B	¥ 3.29B	¥ 2.76B	¥ 2.58B	¥ 2.95B
Operating Income	¥ 1.10B	¥ 980.05M	¥ 866.68M	¥ 785.18M	¥ 759.02M
EBITDA	¥ 1.26B	¥ 1.11B	¥ 991.28M	¥ 878.91M	¥ 846.19M
Net Income	¥ 986.71M	¥ 861.79M	¥ 769.14M	¥ 661.70M	¥ 625.57M
Balance Sheet
Cash & Short-Term Investments	¥ 2.19B	¥ 2.88B	¥ 2.28B	¥ 1.99B	¥ 1.52B
Total Assets	¥ 10.23B	¥ 10.16B	¥ 9.07B	¥ 8.28B	¥ 7.84B
Total Debt	¥ 325.58M	¥ 257.91M	¥ 33.17M	¥ 32.71M	¥ 33.67M
Net Debt	¥ -1.80B	¥ -2.62B	¥ -2.25B	¥ -1.95B	¥ -1.45B
Total Liabilities	¥ 3.58B	¥ 3.61B	¥ 2.55B	¥ 2.33B	¥ 2.32B
Stockholders' Equity	¥ 6.60B	¥ 6.52B	¥ 6.36B	¥ 5.81B	¥ 5.39B
Cash Flow
Free Cash Flow	¥ 547.56M	¥ 569.34M	¥ 695.45M	¥ 482.26M	¥ 289.87M
Operating Cash Flow	¥ 688.49M	¥ 677.25M	¥ 852.40M	¥ 671.42M	¥ 495.49M
Investing Cash Flow	¥ -568.91M	-	-	¥ 73.77M	-
Financing Cash Flow	¥ -833.77M	-	-	-	-

Currency in CNY

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Earnings and Revenue History

Income Statement >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Debt to Assets

Balance Sheet >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Cash Flow

Cash Flow >

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing